0.26
-0.006 (-2.26%)
-0.006 (-2.26%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Onconova Therapeutics Inc | ONTX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.006 | -2.26% | 0.26 | 17:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.2665 | 0.26 | 0.269 | 0.26 | 0.266 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 0.2641 | 0.268 | 0.0039 | 1 | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 3,441 | 3,540,492 | $ 0.2640169 | $ 934,750 | 5,668,887 | 0.126 - 1.56 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:58:56 | formt | 3,899 | $ 0.268 | USD |
Onconova Therapeutics Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 48.09M | 184.95M | 183.37M | $ 2.18M | $ - | -1.50 | 0.20 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | -712.23k | 0.60% |
Onconova Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ONTX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.2735 | 0.278 | 0.255 | 0.2654777 | 6,240,570 | -0.0135 | -4.94% |
| 1 Month | 0.27 | 0.295 | 0.24 | 0.266156 | 5,631,773 | -0.01 | -3.7% |
| 3 Months | 0.22 | 0.4396 | 0.1901 | 0.2978857 | 11,905,012 | 0.04 | 18.18% |
| 6 Months | 0.3759 | 1.56 | 0.1901 | 0.5660534 | 15,403,379 | -0.1159 | -30.83% |
| 1 Year | 0.1323 | 1.56 | 0.126 | 0.4838625 | 15,756,470 | 0.1277 | 96.52% |
| 3 Years | 26.85 | 39.975 | 0.1027 | 0.9832419 | 5,846,213 | -26.59 | -99.03% |
| 5 Years | 21.75 | 122.55 | 0.1027 | 1.48 | 3,582,161 | -21.49 | -98.8% |
Onconova Therapeutics Description
| Onconova Therapeutics Inc is a clinical-stage biopharmaceutical company operating in the US. It focuses on discovering and developing novel small molecule product candidates primarily to treat cancer. The company has created a library of targeted agents designed to work against cellular pathways important to cancer cells. Its product candidates are Single-agent IV rigosertib, Oral rigosertib + azacitidine, IV Briciclib, Recilisib, and ON 123300. The key product candidate Rigosertib is a small molecule which blocks signaling by targeting RAS effeccellular tor pathways. |
